Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 4/20 | 0.60 |
| ▸ | CTSS | P25774 | 1/20 | 0.60 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.59 |
| ▸ | NPC1 | O15118 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.49 |
| ▸ | MAOA | P21397 | 1/20 | 0.49 |
| ▸ | MAOB | P27338 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | CCR6 | P51684 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | APAF1 | O14727 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3475103 | 0.98 | CTSK (0.57) | CTSKCTSSEPHX1NPC1RAB9A | |
| SCHEMBL15739641 | 0.94 | CTSK (0.54) | CTSKCTSSEPHX1NPC1RAB9A | |
| SCHEMBL12733191 | 0.90 | CCR6 (0.49) | CTSKCTSSEPHX1NPC1RAB9A | |
| SCHEMBL3400048 | 0.83 | MAPT (0.61) | EPHX1NPC1RAB9AMAPTLMNA | |
| SCHEMBL11526941 | 0.83 | MAPT (0.61) | EPHX1NPC1RAB9AMAPTLMNA | |
| SCHEMBL78145 | 0.83 | MAPT (0.61) | EPHX1NPC1RAB9AMAPTLMNA | |
| SCHEMBL377685 | 0.83 | CTSS (0.48) | CTSKCTSSEPHX1TRPA1CCR6 | |
| Hydrochloric Acid SCHEMBL23302911 | 0.81 | CTSS (0.47) | CTSKCTSSEPHX1TRPA1CCR6 | |
| SCHEMBL16480090 | 0.81 | CCR6 (0.47) | CTSKCTSSEPHX1NPC1RAB9A | |
| SCHEMBL13450562 | 0.81 | CCR6 (0.47) | CTSKCTSSEPHX1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110313158-A1 | Two Component Recyclable Heterogeneous Catalyst, Process for Preparation Thereof and its Use for Preparation of Amines | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2011-12-22 | — | — | US | claimed |
| WO-2010097815-A2 | A TWO COMPONENT RECYCLABLE HETEROGENEOUS CATALYST, PROCESS FOR PREPARATION THEREOF AND ITS USE FOR PREPARATION OF AMINES | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2010-09-02 | — | — | WO | claimed |
| US-20240051974-A1 | DIRECT REDUCTIVE AMINATIONS WITH MONOTRIFLUOROACETOXY BORANE-AMINES | PURDUE RESEARCH FOUNDATION (US) | 2024-02-15 | — | — | US | disclosed |
| CN-105814087-B | Polymers functionalized with imine compounds containing cyano groups | 株式会社普利司通 | 2017-07-11 | — | — | CN | disclosed |
| CN-105814087-A | Polymers functionalized with imine compounds containing cyano groups | 株式会社普利司通 | 2016-07-27 | — | — | CN | disclosed |
| CN-105646576-A | Efficient and novel method for preparing aminophosphonate through catalytic synthesis of hafnium tetrachloride | 江西科技师范大学 | 2016-06-08 | — | — | CN | disclosed |
| CN-103998935-A | Hsp90 combination therapy | SLOAN KETTERING INST CANCER | 2014-08-20 | — | — | CN | disclosed |
| US-20110313158-A1 | Two Component Recyclable Heterogeneous Catalyst, Process for Preparation Thereof and its Use for Preparation of Amines | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2011-12-22 | — | — | US | disclosed |
| WO-2010097815-A2 | A TWO COMPONENT RECYCLABLE HETEROGENEOUS CATALYST, PROCESS FOR PREPARATION THEREOF AND ITS USE FOR PREPARATION OF AMINES | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2010-09-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110313158-A1 | Two Component Recyclable Heterogeneous Catalyst, Process for Preparation Thereof and its Use for Preparation of Amines | HCN2, RAC2, HCN1 | CTSK 2119/4885CTSS 1237/4885EPHX1 636/4885 |
| US-20240051974-A1 | DIRECT REDUCTIVE AMINATIONS WITH MONOTRIFLUOROACETOXY BORANE-AMINES | MAOB, BCAT2, AADAT | CTSK 1619/4885CTSS 1756/4885EPHX1 3224/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.